These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 15799969

  • 1. Nuclear targeting of transforming growth factor-beta-activated Smad complexes.
    Chen HB, Rud JG, Lin K, Xu L.
    J Biol Chem; 2005 Jun 03; 280(22):21329-36. PubMed ID: 15799969
    [Abstract] [Full Text] [Related]

  • 2. Transforming growth factor beta-independent shuttling of Smad4 between the cytoplasm and nucleus.
    Pierreux CE, Nicolás FJ, Hill CS.
    Mol Cell Biol; 2000 Dec 03; 20(23):9041-54. PubMed ID: 11074002
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II.
    Wicks SJ, Lui S, Abdel-Wahab N, Mason RM, Chantry A.
    Mol Cell Biol; 2000 Nov 03; 20(21):8103-11. PubMed ID: 11027280
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Transforming growth factor-beta induces nuclear import of Smad3 in an importin-beta1 and Ran-dependent manner.
    Kurisaki A, Kose S, Yoneda Y, Heldin CH, Moustakas A.
    Mol Biol Cell; 2001 Apr 03; 12(4):1079-91. PubMed ID: 11294908
    [Abstract] [Full Text] [Related]

  • 7. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
    Fink SP, Mikkola D, Willson JK, Markowitz S.
    Oncogene; 2003 Mar 06; 22(9):1317-23. PubMed ID: 12618756
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
    Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH, Miyazono K, ten Dijke P.
    EMBO J; 1997 Sep 01; 16(17):5353-62. PubMed ID: 9311995
    [Abstract] [Full Text] [Related]

  • 10. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
    Itoh S, Ericsson J, Nishikawa J, Heldin CH, ten Dijke P.
    Nucleic Acids Res; 2000 Nov 01; 28(21):4291-8. PubMed ID: 11058129
    [Abstract] [Full Text] [Related]

  • 11. An extended bipartite nuclear localization signal in Smad4 is required for its nuclear import and transcriptional activity.
    Xiao Z, Latek R, Lodish HF.
    Oncogene; 2003 Feb 20; 22(7):1057-69. PubMed ID: 12592392
    [Abstract] [Full Text] [Related]

  • 12. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein.
    Yingling JM, Datto MB, Wong C, Frederick JP, Liberati NT, Wang XF.
    Mol Cell Biol; 1997 Dec 20; 17(12):7019-28. PubMed ID: 9372933
    [Abstract] [Full Text] [Related]

  • 13. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.
    Felici A, Wurthner JU, Parks WT, Giam LR, Reiss M, Karpova TS, McNally JG, Roberts AB.
    EMBO J; 2003 Sep 01; 22(17):4465-77. PubMed ID: 12941698
    [Abstract] [Full Text] [Related]

  • 14. Functional cloning of the proto-oncogene brain factor-1 (BF-1) as a Smad-binding antagonist of transforming growth factor-beta signaling.
    Rodriguez C, Huang LJ, Son JK, McKee A, Xiao Z, Lodish HF.
    J Biol Chem; 2001 Aug 10; 276(32):30224-30. PubMed ID: 11387330
    [Abstract] [Full Text] [Related]

  • 15. Molecular and functional consequences of Smad4 C-terminal missense mutations in colorectal tumour cells.
    De Bosscher K, Hill CS, Nicolás FJ.
    Biochem J; 2004 Apr 01; 379(Pt 1):209-16. PubMed ID: 14715079
    [Abstract] [Full Text] [Related]

  • 16. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC, de Caestecker MP, Schnaper HW.
    Kidney Int; 1999 Oct 01; 56(4):1354-65. PubMed ID: 10504488
    [Abstract] [Full Text] [Related]

  • 17. Sorting nexin 9 differentiates ligand-activated Smad3 from Smad2 for nuclear import and transforming growth factor β signaling.
    Wilkes MC, Repellin CE, Kang JH, Andrianifahanana M, Yin X, Leof EB.
    Mol Biol Cell; 2015 Nov 01; 26(21):3879-91. PubMed ID: 26337383
    [Abstract] [Full Text] [Related]

  • 18. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S, Firth SM, Baxter RC.
    J Biol Chem; 2002 Mar 01; 277(9):7255-61. PubMed ID: 11751851
    [Abstract] [Full Text] [Related]

  • 19. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
    Yuan W, Varga J.
    J Biol Chem; 2001 Oct 19; 276(42):38502-10. PubMed ID: 11502752
    [Abstract] [Full Text] [Related]

  • 20. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling.
    Goto D, Nakajima H, Mori Y, Kurasawa K, Kitamura N, Iwamoto I.
    Biochem Biophys Res Commun; 2001 Mar 19; 281(5):1100-5. PubMed ID: 11243848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.